About: Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases. It develops IMVT-1402, a human monoclonal antibody that inhibits neonatal fragment crystallizable receptor for graves' disease, rheumatoid arthritis, sjögren's disease, cutaneous lupus erythematosus disease, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy. The company was founded in 2018 and is based in Durham, North Carolina. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.
Sector: Healthcare
Industry: Biotechnology
Latest price: $29.04 (+2.22%)
IMVT NASDAQ Immunovant Inc
Immunovant Inc share price
IMVT price activity
Last Price
$29.040
Change (24hr)
0.63 USD (2.22%)
Volume
1.08M
Volume (4w avg)
-
Open
$28.70
Day Range
$28.42 - $29.48
Previous Close
$28.41
Last Trade
03 Nov, 9:00 pm GMT+0
Delayed
03 Nov, 9:00 pm GMT+0
IMVT price performance
Delayed
03 Nov, 9:00 pm GMT+0
IMVT details
IMVT Market Signals